Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated with Severe Sepsis at Admission

Medicine (United States)

Volumn 95, Issue 20, 2016, Pages

  Lee, Yi Chien ^a   Hsiao, Chih Yen ^a,b   Hung, Miao Chiu ^c   Hung, Sheng Che ^d,e   Wang, Hung Ping ^a   Huang, Yun Jhong ^a   Wang, Jann Tay ^f  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c Department of Pediatrics ^*  (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFUROXIME; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTEREMIC URINARY TRACT INFECTION; CITROBACTER; CLINICAL FEATURE; ENTEROBACTERIACEAE; FEMALE; GOUT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYDRONEPHROSIS; INDWELLING URINARY CATHETER; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; KLEBSIELLA PNEUMONIAE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIDRUG RESISTANT ENTEROBACTERIACEAE; NEPHROLITHIASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA RETTGERI; RECURRENT INFECTION; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SERRATIA MARCESCENS; URETER STONE; URINARY TRACT INFECTION; ADVERSE EFFECTS; AGED; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; INDWELLING CATHETER; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SHOCK, SEPTIC; URINARY CATHETER; URINARY TRACT INFECTIONS; UROLITHIASIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERS, INDWELLING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; HYDRONEPHROSIS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SHOCK, SEPTIC; URINARY CATHETERS; URINARY TRACT INFECTIONS; UROLITHIASIS;

EID: 84973549997     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003694     Document Type: Article

References (32)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113:5S-13S.
2. Velasco M, Martínez JA, Moreno-Martínez A, et al. Blood cultures for women with uncomplicated acute pyelonephritis: Are they necessary? Clin Infect Dis. 2003;37:1127-1130.
3. Bahagon Y, Raveh D, Schlesinger Y, et al. Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis. 2007;26:349-352.
4. Van Nieuwkoop C, Bonten TN, Wout JW, et al. Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis. 2010;50:e69-e72.
5. Hsu CY, Fang HC, Chou KJ, et al. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci. 2006;332: 175-180.
6. Lee JH, Lee YM, Cho JH. Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. J Infect Chemother. 2012;18:130-133.
7. Shaw E, Benito N, Rodríguez-Baño J, et al. Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: impact of antimicrobial resistance in a large hospitalised cohort. J Infect. 2015;70:247-254.
8. Munford RS, Suffredini AF. Sepsis, Severe Sepsis, and Septic Shock.Chapter 75. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennetts Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: The Churchill Livingstone Elsevier; 2015.
9. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-Acquired, ventilator-Associated, and healthcare-Associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
10. Piatti G, Mannini A, Balistreri M, et al. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol. 2008;46:480-487.
11. Freeman JT, McBride SJ, Nisbet MS, et al. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes. Int J Infect Dis. 2012;16:e371-e374.
12. Park YS, Bae IK, Kim J, et al. Risk factors and molecular epidemiology of community-onset extended-spectrum b-lactamase-producing Escherichia coli bacteremia. Yonsei Med J. 2014;55:467-475.
13. Honkinen O, Jahnukainen T, Mertsola J, et al. Bacteremic urinary tract infection in children. Pediatr Infect Dis J. 2000;19:630-634.
14. Hsiao CY, Yang HY, Chang CH, et al. Risk factors for development of septic shock in patients with urinary tract infection. Biomed Res Int. 2015;2015:717094.
15. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
16. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: A commentary. Int J Antimicrob Agents. 1999;11:7-12.
17. American College of Chest Physician/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20:864-874
18. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.
19. Hsiao CY, Yang HY, Hsiao MC, et al. Risk factors for development of acute kidney injury in patients with urinary tract infection. PLoS One. 2015;10:e0133835.
20. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17 Wayne, PA: CLSI; 2007.
21. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement M100-S23 Wayne, PA: CLSI; 2013.
22. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-281.
23. Oliveira MC, Oliveira CR, Goncalves KV, et al. Enterobacteriaceae resistant to third generation cephalosporins upon hospital admission: risk factors and clinical outcomes. Braz J Infect Dis. 2015;19:239-245.
24. Wu YH, Chen PL, Hung YP, et al. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J Microbiol Immunol Infect. 2014;47:197-203.
25. Arslan H, Azap OK, Ergönül O, et al. Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-Acquired urinary tract infections in Turkey. J Antimicrob Chemother. 2005;56:914-918.
26. Alós JI, Serrano MG, Gómez-Garcés JL, et al. Antibiotic resistance of Escherichia coli from community-Acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect. 2005;11:199-203.
27. Ortega M, Marco F, Soriano A, et al. Cefotaxime resistance and outcome of Klebsiella spp bloodstream infection. Eur J Clin Microbiol Infect Dis. 2011;30:1599-1605.
28. Peralta G, Sánchez MB, Garrido JC, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother. 2007;60:855-863.
29. Mauldin PD, Salgado CD, Hansen IS, et al. Attributable hospital cost and length of stay associated with health care-Associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother. 2010;54:109-115.
30. Thulstrup AM, Sorensen HT, Schonheyder HC, et al. Populationbased study of the risk and short-Term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis. 2000;31:1357-1361.
31. Shigemura K, Tanaka K, Osawa K, et al. Clinical factors associated with shock in bacteremic UTI. Int Urol Nephrol. 2013;45:653-657.
32. Beceiro A, Tomás M, Bou G. Antimicrobial resistance and virulence: A successful or deleterious association in bacterial world? Clin Microbiol Rev. 2013;26:185-230.